Pyronaridine Artesunate (3:1)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pyronaridine Artesunate (3:1), covering 2021-09-20 to 2021-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria [Phase 2]